FWBI - First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024 | Benzinga
BOCA RATON, Fla., Feb. 13, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), ("First Wave BioPharma" or the "Company"), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that James Sapirstein, Chairman and CEO of First Wave BioPharma, will present at the BIO CEO & Investor Conference, which is planned for February 26-27, 2024, at the Marriott Marquis in New York City.
Details of the event are as follows:
| Event: |
| BIO CEO & Investor Conference |
| Presentation |
| February 27, 1:15 PM, EST |
| Location: |
| The Plymouth Room, Marriott Marquis, New York City |